Cargando…
Immunotherapy of WAP-T(NP) mice with early stage mammary gland tumors
The SV40 transgenic BALB/c mouse based WAP-T/WAP-T(NP) model for triple-negative breast cancer allows the analysis of parameters influencing immunotherapeutic approaches. Except for WAP-T(NP) tumors expressing the immune-dominant LCMV NP-epitope within SV40 T-antigen (T-Ag(NP)) which is not expresse...
Autores principales: | Bruns, Michael, Deppert, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620212/ https://www.ncbi.nlm.nih.gov/pubmed/28978072 http://dx.doi.org/10.18632/oncotarget.18850 |
Ejemplares similares
-
T-cell epitope strength in WAP-T mouse mammary carcinomas is an important determinant in PD1/PD-L1 immune checkpoint blockade therapy
por: Bruns, Michael, et al.
Publicado: (2016) -
Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells
por: Maenz, Claudia, et al.
Publicado: (2015) -
Mammary-Enriched Transcription Factors Synergize to Activate the Wap Super-Enhancer for Mammary Gland Development
por: Kim, Uijin, et al.
Publicado: (2022) -
Tumorigenic WAP-T Mouse Mammary Carcinoma Cells: A Model for a Self-Reproducing Homeostatic Cancer Cell System
por: Wegwitz, Florian, et al.
Publicado: (2010) -
Assessment of the WAP-Myc mouse mammary tumor model for spontaneous metastasis
por: Utz, Begüm, et al.
Publicado: (2020)